Circulating Ephrin–Eph Signaling Reflects Interstitial Fibrosis and Tubular Atrophy in Diabetic Kidney Disease
Clinical Journal of the American Society of Nephrology · 2026-11 · 21 (11) · 1936-1947
DOI: 10.2215/cjn.0000001191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 21.08.2026. Verfasst von Seung Seok Han und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Mass General Brigham, Boston, Massachusetts. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Ephrins, Kidney Tubules, Receptors, Eph Family. Die Arbeit nennt 54 Literaturangaben. Gefördert von: NIDDK NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Key Points The ephrin–Eph signaling pathway emerged as the strongest blood proteomic correlate of interstitial fibrosis and tubular atrophy burden in a biopsy-confirmed diabetic kidney disease cohort. This association was independently validated in 2 external multiethnic cohorts and was associated with a higher risk of subsequent kidney failure. Kidney multiome analyses linked ephrin–Eph signaling to intrarenal epithelial–mesenchymal transition–related molecular programs in diabetic kidney.
Background
Diabetic kidney disease (DKD) is characterized by heterogeneous renal histological patterns, among which interstitial fibrosis and tubular atrophy (IFTA) is a key determinant of patient outcomes and treatment response. However, blood biomarkers reflecting IFTA burden remain unestablished.
Methods
We conducted SomaScan-based blood proteomic profiling in Korean patients with biopsy-confirmed diabetic nephropathy from the Seoul National University Hospital ( n =129). Linear regression analyses were used to identify pathways associated with IFTA area, and those additionally upregulated compared with healthy individuals were prioritized. Findings were validated in 2 external cohorts with available SomaScan data and histologic IFTA assessment: the Kidney Precision Medicine Project (KPMP; n =73) and the Boston Kidney Biopsy Cohort ( n =414). Renal expression and downstream signaling of pathway components were evaluated using human kidney multiome data from KPMP.
Results
In the diabetic nephropathy from Seoul National University Hospital cohort, the ephrin receptor signaling pathway emerged as the top pathway both positively associated with IFTA area and upregulated in patients with DKD. This association was replicated in the KPMP and Boston Kidney Biopsy Cohort cohorts. High activity of the ephrin receptor signaling pathway was also associated with a higher risk of kidney failure. Kidney tissue analyses demonstrated a higher expression of ephrin–Eph signaling components, particularly genes encoding EPHA4 and EPHB1, in diabetic kidneys. Renal expression of these genes correlated with epithelial–mesenchymal transition signatures, accompanied by downstream activation of hypoxia, Janus kinase–signal transducer and activator of transcription, and TGF β signaling pathways across multiple kidney cell types.
Conclusions
Upregulation of the ephrin receptor signaling pathway represents a robust and reproducible blood proteomic signature reflecting IFTA in DKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, Mass General Brigham, Boston, Massachusetts.
- Endocrine Unit, Department of Medicine, Mass General Brigham, Boston, Massachusetts.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
- Department of Medicine, New York University Grossman School of Medicine, New York, New York.
- Section of Nephrology, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts.
- Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
ORCID-Profile: Seung Seok Han, Aditya L Surapaneni, Insa M Schmidt, Donghwan Yun, Xufan Ma, Kyung Chul Moon, Anand Srivastava, Isaac E Stillman, Morgan E Grams, Eugene P Rhee
Förderung
- NIDDK NIH HHS
- NIH HHS
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Han, S. S., Surapaneni, A. L., Schmidt, I. M., Yun, D., Ma, X., Moon, K. C., Srivastava, A., Palsson, R., Stillman, I. E., Waikar, S. S., Grams, M. E., & Rhee, E. P. (2026). Circulating Ephrin–Eph Signaling Reflects Interstitial Fibrosis and Tubular Atrophy in Diabetic Kidney Disease. Clinical Journal of the American Society of Nephrology, 21(11), 1936-1947. https://doi.org/10.2215/cjn.0000001191
Vancouver
Han SS, Surapaneni AL, Schmidt IM, Yun D, Ma X, Moon KC, et al. Circulating Ephrin–Eph Signaling Reflects Interstitial Fibrosis and Tubular Atrophy in Diabetic Kidney Disease. Clinical Journal of the American Society of Nephrology. 2026;21(11):1936-1947. doi:10.2215/cjn.0000001191
BibTeX
@article{Han2026,
author = {Han, Seung Seok and Surapaneni, Aditya L and Schmidt, Insa M and Yun, Donghwan and Ma, Xufan and Moon, Kyung Chul and Srivastava, Anand and Palsson, Ragnar and Stillman, Isaac E and Waikar, Sushrut S and Grams, Morgan E and Rhee, Eugene P},
title = {Circulating Ephrin–Eph Signaling Reflects Interstitial Fibrosis and Tubular Atrophy in Diabetic Kidney Disease},
journal = {Clinical Journal of the American Society of Nephrology},
year = {2026},
volume = {21},
number = {11},
pages = {1936--1947},
doi = {10.2215/cjn.0000001191}
}
EUVIMED